CD274 and neoplasm: Tumor cell escape from immune surveillance by upregulating the expression of PD-1 and PD-L1 in the tumor microenvironment, and immunotherapy activate immune activities by blocking the interaction of PD-1/PD-L1 (Tumeh et al., 2014).